Cardiotoxicity

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy [NA]

  This clinical trial update reports ongoing recruitment for a study using serial cardiac MRI with contrast agents and biomarker analysis to d…

• CLINICAL_TRIALS research · 2026-03-18
  Clinical Trial Update: Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial [NA]

  This clinical trial assesses how different exercise intensities affect cardiac health in young adult survivors of childhood cancer, with no …

• CLINICAL_TRIALS research · 2026-02-11
  Clinical Trial Update: Artificial Intelligence for Reconstruction of Echocardiography Studies

  An update on a clinical trial evaluating an artificial intelligence approach to reconstruct echocardiography studies for monitoring cardioto…

• CLINICAL_TRIALS research · 2025-11-21
  Clinical Trial Update: Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines [Phase 3]

  Phase 3 trial evaluating empagliflozin to prevent anthracycline-induced cardiotoxicity in cancer patients; recruitment is ongoing.

• CLINICAL_TRIALS research · 2025-10-14
  Clinical Trial Update: PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

  This feasibility study evaluates using patient similarity to support decision-making in preventing cardiovascular toxicity.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2024-12-05
  Clinical Trial Update: Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy [NA]

  This update describes a clinical trial evaluating aerobic exercise as a cardio-protective strategy for patients with hematologic cancers exp…

• CLINICAL_TRIALS research · 2023-08-22
  Clinical Trial Update: Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) [Phase 4]

  A Phase 4 trial evaluating whether spironolactone can prevent cardiotoxicity caused by anthracycline chemotherapy.